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ABSTRACT
Effect of a High Protein Diet On 
Glucose Tolerance in Rats
by
Roxanne Mary Sanchez
Dr. John C. Young, Examination Committee Chair 
Professor o f Kinesiology 
University o f Nevada, Las Vegas
The purpose of this study was to determine the effects of a high protein diet on 
glucose tolerance in the rat model. Nine Sprague Dawley rats received a high protein diet 
(65% protein, 35% fat) and eight rats consumed a standard chow diet over the course o f 
eight weeks. An oral glucose tolerance test (OGTT) was performed at the end of the 
third and the seventh week to measure blood glucose and plasma insulin concentrations. 
The diet did not effeet glucose toleranee in the first OGTT (t = 1.2095, p = .1226) or the 
second OGTT (t = -.9855, p = .1700) as reflected by the area under the glueose 
concentration curve. Similarly, the high protein diet did not effect the area under the 
insulin concentration curve during the first OGTT (t = .5425, p = .2978) or the second 
OGTT (t = . 1709, p = .4333).
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CHAPTER 1 
INTRODUCTION
The purpose of this study is to determine the effects of a high protein diet on glucose 
tolerance in the rat model. At any given time in the United States, approximately 45% of 
women and 30% of men are trying to lose weight (Foster et ah, 2003). Fad diets have 
become an increasingly preferred method in the attempt to manage weight. A recently 
popular diet is one characterized by a high protein and high fat content and severely 
limited carbohydrate intake. High protein diets, such as this, emphasize that excess 
carbohydrate intake results in elevated insulin which promotes the storage of energy as 
fat. By reducing carbohydrates, proponents of these diets claim that insulin levels will be 
lowered and thus, storage of fat will be decreased (Atkins, 2002). However, these plans 
fail to consider that certain amino acids also stimulate insulin secretion (Liu, Long, 
Hillier, Saffer, & Barrett, 1999). High levels of insulin secretion have been associated 
with hyperinsulinemia, glucose intolerance and the metabolic syndrome (American 
Diabetes Association, 2004). Conversely, a low carbohydrate diet has been shown to 
lead to an improvement in insulin sensitivity in glucose intolerant patients (Parillo et al., 
1992). The mechanism for improved insulin sensitivity with low carbohydrate diets is 
unclear.
Insulin activates glucose uptake by mobilizing glucose transporters (GLUT4) from an 
intracellular pool to the plasma membrane via a phosphatidylinositol kinase (PI 3 kinase)
I
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signaling pathway. Muscle contraction or exercise stimulates glucose uptake by an 
insulin independent pathway. Muscle contraction also translocates GLUT4 transporters 
to the plasma membrane; however stimulation by contractile activity is mediated by the 
activation of AMP kinase and high energy phosphates. The independence of these 
pathways is demonstrated by tbe fact tbat the stimulatory effects of maximum insulin 
exposure and maximum contractile activity on glucose uptake are completely additive 
(Nesher, Karl, & Kipnis, 1985). Muscle glycogen can be partially depleted by a diet low 
in carbohydrates and through physical activity, however subsequent glucose uptake upon 
refeeding is only increased by 50% for dieters compared with the rate of glucose uptake 
for depletion via exercise (Young, Garthwaite, Bryan, Cartier, & Holloszy, 1983). Thus, 
it remains to be determined if a high protein-low carbohydrate diet will have deleterious 
effects on either insulin stimulated or contraction stimulated glucose uptake.
There have been relatively few studies on the short and long-term effects of high 
protein-low carbohydrate diets on health (Saltzman, Thomason, & Roberts, 2001). The 
trials were typically short, uncontrolled and included few subjects. The metabolic effects 
of high protein diets needs to be studied in terms of insulin dynamics as this has 
important implications for type 2 diabetes, glucose intolerance and insulin resistance. 
Furthermore, the role that these diets may play in the development of coronary artery 
disease and changes in the blood lipid profile have also not been clearly established (St 
Jeor, Howard, Prewitt, Bovee, Bazzarre, & Eckel, 2001). Lastly, high protein diets may 
have negative effects on bone and renal health, but this has not been fully identified 
(Saltzman et ah, 2001).
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Purpose o f the Study
The purpose of this study is to determine if  a long-term high protein diet has adverse 
effects on glucose tolerance in normal adult female Sprague Dawley rats.
Specific Research Hypothesis
1. Research Hypothesis: Long-term adherence to a high protein diet will have adverse 
effects on glucose tolerance because deprivation o f dietary carbohydrates will alter 
insulin sensitivity and responsiveness.
2. Null Hypothesis: Long-term adherence to a high protein diet will not have adverse 
effects on glucose tolerance.
The following definitions guided this study:
1. Independent variable: High protein diet
2. Dependent variable: Glucose and insulin response over time to an oral glucose 
challenge.
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CHAPTER 2
REVIEW OE THE LITERATURE 
Mechanism of Glucose Transport 
The Glucose Transport System
Glucose transport aeross the phospholipid bilayer of cell membranes in skeletal 
muscle is a major rate-limiting step in glucose utilization (Ziel, Venkatesan, & Davidson, 
1988). Entry o f glucose across the cell membrane occurs via facilitated diffusion 
utilizing glucose transporter proteins, specifically GLUT4. This is a passive process that 
does not require adenosine triphosphate (ATP) for energy and follows saturation kinetics, 
which means that diffusion occurs by an increase in the maximal velocity of transport 
(Vmax) without an appreciable change in the Km, the substrate’s concentration at which 
glucose transport is half maximal (Goodyear & Kahn, 1998). The evidence indicates that 
there are two distinct pools of glucose transporter proteins: one that is activated via 
insulin and the other by contraction or exercise (Nesher et al., 1985).
Glucose Transporter Translocation
GLUT4 is the major glucose transporter protein present in mice, rats and humans. 
GLUT I and GLUT5 isoforms are also evident, but do not respond to the stimulus of 
insulin or contractile activity (Douen et ah, 1990). GLUT4 accounts for the majority of 
postprandial glucose uptake (Thurmond, Wadsworth, Schafer, Zivin, & Siekierka, 2001). 
Fat and muscle cells are sensitive to insulin and will respond by releasing GLUT4 from
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their intracellular storage compartment for translocation to the cell membrane. The exact 
location o f the intracellular pools of GLUT4 for insulin and contraction stimulated 
glucose uptake are not known, but may be somewhere in the trans-Golgi region (Etgen, 
Memon, Thompson, & Ivy, 1993). The rate of glucose transport into fat and muscle cells 
is a function of the number of GLUT4 transporters mobilized to the cell surface and 
length of time the transporters remain incorporated into the cell membrane (Saltiel & 
Pessin, 2002).
The mobilization of GLUT4 transporters to the cell membrane involves two separate 
pathways: insulin-dependent and insulin-independent, mainly stimulated by contraction 
and hypoxia. The best evidence for independent pathways is the nearly completely 
additive effects of insulin and contraction on glucose transport. That is the increase in 
muscle glucose transport is twice as great when maximal insulin stimulus is combined 
with maximal contractile activity than the rate o f transport with either insulin or 
contraction alone (Nesher et ah, 1985). Also, studies have demonstrated that insulin and 
contractile activity access GLUT4 from distinct intracellular pools (Douen et ah, 1990).
GLUT4 translocation involves three general steps as described by Thurmond et al. 
(2001). First, GLUT4 vesicles are mobilized out o f the storage pool. Then, vesicles are 
docked just below the cell surface and primed via the interactions of the SNARE proteins 
(a family of membrane-tethered coiled-coil proteins that are required for membrane 
fusion in exocytosis and other transport processes) present on the vesicular and plasma 
membranes. Finally, GLUT4 vesicles are fused with the plasma membrane. The precise 
mechanism of the trafficking pathways remains to be determined. However, it is known 
that when GLUT4 is present on the surface of the plasma membrane and the transverse
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tubules, the number stored in the intracellular pool declines (Khayat, Patel, & Klip,
2002^
Insulin Stimulated Glucose Transport 
The insulin receptor is a heterodimer containing two alpha and two beta subunits.
The first step in the regulation of glucose transport via the insulin-stimulated pathway 
involves the binding of insulin to the extracellular alpha subunit o f the receptor. 
Following this event, the insulin receptor’s beta subunit acts as a tyrosine kinase to cause 
phosphorylation of the insulin receptor substrates (1RS) (White & Kahn, 1994). The 1RS, 
specifically 1RS 1 and 1RS 2, are thought to play key roles as docking proteins for 
downstream signaling molecules containing phosphatidylinositol kinase (PI 3-kinase) 
(White, 1998). PI 3-kinase is the signal that leads to GLUT4 mobilization in skeletal 
muscle and adipocytes during insulin-mediated glucose transport (Goodyear, Giorgino, 
Sherman et al., 1995). This was demonstrated when Wojtaszewski, Hansen, Urso and 
Richter (1996) used wortmannin to inhibit PI 3-kinase, which resulted in inhibition of 
insulin stimulated glucose uptake and transport into skeletal muscle.
Contraction Stimulated Pathway 
Early studies by Holloszy and Narahara (1965) on frog sartorius muscle introduced 
novel ideas in the area of glucose metabolism. These studies first demonstrated that 
muscle contraction has an insulin-like effect on glucose transport. They also showed that 
this effect is due to an increase in the number of transport sites rather than an increase in 
the affinity of the transport sites for glucose. Subsequent studies provided evidence that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
exercise training, independent of an acute session, can increase the number of GLUT4 
transporters in skeletal muscle (Goodyear, Hirshman, Valyou, & Horton, 1992).
Several intracellular signals have been proposed as the trigger for the translocation of 
GLUT4 to the plasma membrane during contractile activity. Two such signals are the 
adenylate cyclase-adenosine 3’5’-cyclie monophosphate (eAMP), and alterations, 
specifically decreases, in the eoncentration of high energy phosphates. Yaspelkis, Castle, 
Farrar, and Ivy (1997) studied low ffequeney eleetrical stimulation over the course of 30 
days to analyze the effects on GLUT4 and found a decline in GLUT4 protein 
concentration after 3 days of stimulation, which returned to control group levels within 7 
days, and then increased after 14 and 28 days o f stimulation. Yaspelkis et al. (1997) 
noted that GLUT4 protein coneentrations were inversely related to the high energy 
phosphates o f the cell and directly related to cAMP activity. Thus, the results suggest 
that both high-energy phosphates and cAMP play key roles in the intracellular signaling 
that regulates contraction-induced translocation o f GLUT4 proteins.
A role for intracellular calcium in activating contraction stimulated glucose uptake 
has also been proposed. During muscle contraction, calcium is released trom the 
sarcoplasmic reticulum. Early studies performed on frog sartorius muscle showed that it 
was the frequency of contraction that determined the rate of glucose transport via the 
insulin-independent pathway, not the amount o f tension produced in the muscle or work 
performed (Holloszy & Narahara, 1965). Several studies have since used agents, such as 
caffeine, to increase cytosolic calcium in the absence of eontraetion and found an 
increase in glucose uptake in muscle (Holloszy, Constable & Young, 1986). Conversely, 
Nolte et al. (1995) used dantrolene to prevent the sarcoplasmic reticulum from releasing
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calcium and demonstrated an inhibition of glucose uptake during contraction. Pereira 
and Lancha (2004) suggest that the calcium ions themselves are not directly activating 
contraction stimulated glucose transport as cytoplasmic calcium concentrations are 
increased for just milliseconds after each muscle contraction, while glucose transport 
remains elevated after exercise has ceased. Khayat et al. (2002) suggests that the 
transient fall in cellular ATP concentration following the onset of contraction or hypoxia 
would inhibit the Na-K ATPase pump. The ensuing membrane depolarization would also 
reduce the Ca ATPase activity affecting calcium reuptake by tbe sarcoplasmic reticulum 
and/or enhance the Na/Ca exchange, resulting in a rise in cytosolic calcium which could 
stimulate GLUT4 translocation. The translocation of GLUT4 to the cell membrane by 
calcium is thought to be mediated by protein kinase C. Diacylglycerol (DAG) is 
responsible for increasing the affinity of protein kinase C for calcium (Nishizuka, 1992). 
To examine this hypothesis, Wojtaszewski, Laustsen, Derave, and Richter (1998) 
administered calphostin C, a protein kinase C inhibitor, and noted that contraction 
stimulated glucose transported was partially inhibited.
In addition to intracellular ealcium, the energy status of the cell has also been 
implicated in the regulation of glucose uptake during contractile activity. AMP-activated 
protein kinase (AMPK) is initiated by phosphorylation during exercise and hypoxia 
(Khayat et al., 2002). Thus, AMPK is activated due to an increase in AMP and a 
decrease in creatine phosphate in contracting skeletal muscle. It is suggested that 
phosphorylation is regulated by the AMP/ATP ratio and the upstream AMPK kinase 
(Stein, Woods, Jones, Davison, & Carling, 2000). AMPK, a heterotrimeric enzyme, can 
directly promote catabolic reactions to generate ATP and inhibit anabolic actions, wbich
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suggests that it is in fact a fuel sensor for the cell. When AMPK activity was stimulated 
by the AMPK activator 5-aminoimidazole-4-carboxamide ribofuranoside (AICAR) there 
was a twofold increase in glucose uptake (Hayashi, Hirshman, Kurth, Winder, & 
Goodyear, 1998). The increased rate of glucose uptake was attributed to the rise in 
GLUT4 translocation and was independent of the insulin stimulated pathway as shown by 
the failure of wortmannin, which inhibits PI 3-kinase, to block the increase. However, 
whether AMPK actually participates in the pathway or simply acts as a sensor for ATP is 
still unclear.
While the evidence suggests calcium and AMPK are both involved in contraction 
mediated glucose uptake, other factors, such as the role that autocrine and paracrine 
mediators may play in this process have been considered. Nitric oxide has been proposed 
as one such intermediate. During muscular contraction, the release o f calcium from the 
sarcoplasmic reticulum is thought to induce the production of nitric oxide (NO). NO has 
previously been shown to have a role in the regulation of local blood flow and it has now 
been proposed as a mediator of glucose uptake. In 1997, Roberts, Barnard, Scheck and 
Balon showed that administering a NOS inhibitor to rats prior to exercise prevented an 
increase in the translocation of contraction-stimulated GLUT4 proteins to the cell 
membrane. Young and Balon (1997) and Balon and Nadler (1997) demonstrated that 
exogenous NO donors increase glucose transport in rat skeletal muscle which is additive 
to insulin, but not to contraction. Furthermore, Balon and Nadler (1997) suggest that 
nitric oxide’s role in glucose transport is regulated by the cAMP pathway.
Adenosine has also been proposed as a potential autocrine/paracrine mediator of 
glucose transport. During muscular contraction, adenosine is produced and can be found
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in the interstitial space. Extracellular adenosine is then believed to act as a local hormone 
by binding to adenosine receptors on adjacent skeletal muscle. Law and Raymond (1988) 
showed that effects o f adenosine and insulin in glucose transport were completely 
additive in skeletal tissue and adipocytes. However, this theory still remains 
controversial until more research can confirm the synergistic effects.
Bradykinin has also been suggested as an autocrine/paracrine mediator as it is 
released from skeletal muscle during activity. Kishi et al. (1998) showed that bradykinin 
directly triggers the translocation of GLUT4 to the plasma membrane through a 
mechanism independent of PI 3-kinase in L6 myotubes, 3T3-LI adipocytes and Chinese 
hamster ovary. Taguehi et al. (2000) administered a bradykinin receptor antagonist to 
rats and noted a complete inhibition of exercise mediated glucose transport. However, 
other studies have implicated bradykinin in the insulin-dependent pathway, thus more 
research is needed to clarify its precise role in glueose transport.
Amino Acid Stimulated Insulin Secretion
During the early twentieth century, the only known natural stimulus to insulin 
secretion was glucose. However, in 1956 Cochrane, Payne, Simpkiss, and Woolf found 
that hypoglycemia could be induced in children with idiopathic familial hypoglycemia 
through the ingestion o f leucine. The exact mechanism for this phenomenon was not 
recognized at the time, but subsequent work by Y alow and Berson in I960 demonstrated 
that oral leucine administration caused an increase in plasma insulin concentration in 
leucine-sensitive subjects.
10
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The hypoglycemic effects o f leucine have also been demonstrated in normal subjects 
when a standard dose of 200 mg per kilogram o f body weight is given orally or 
intravenously (Becker, Clark, & Schwartz, 1964). Intravenous administration of leucine 
will typically result in a greater decrease in blood glucose owing to the higher plasma 
levels o f leucine available to the tissue (Floyd, Fajans, Knopf, & Conn, 1963). The mean 
maximal decrease of blood glucose from oral administration of leucine is 6mg/100 ml 
and 12 mg/100 ml from the intravenous dose.
Amino acid stimulated insulin release is not dependant on a rise in blood glucose. 
While leucine, a ketogenic amino acid, increases insulin secretion, it does not result in an 
increase in blood glucose (Floyd et ah, 1963). However, any initial rise of blood glucose 
seen during the infusion of various amino acids is likely due to gluconeogenesis.
Herrera, Kamm, Ruderman and Cahill (1966) have shown that gluconeogenesis begins 
almost instantaneously once particular amino acids have perfused the liver. The 
subsequent decrease in blood glucose that occurs following the infusion of amino acids is 
the result of the previous insulin secretion. In healthy subjects, the increase in plasma 
insulin from the infusion of amino acids would likely moderate the rise in blood glucose 
caused by gluconeogenesis (Fajans, Floyd, Knopf, & Conn, 1967). In addition, Gannon, 
Nuttall, Lane, and Burmeister (1992) demonstrated that oral administration of amino 
acids with glucose resulted in plasma glucose lowering effects in type 2 diabetics by 11 
to 20% in tbe five hour postprandial period.
In order to determine if  leucine would increase plasma insulin in normal subjects 
under more physiological conditions, Fajans, Floyd, Knopf, and Conn (1964) prepared 
test meals of chicken liver and hamburger with 8.0 and 10.2 grams of leucine
11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
respectively. Another set of subjects were given 14 toi 6 grams of leucine only. After the 
protein meal, the ratio of increase in insulin to leucine was 5.3, while it was 0.7 after the 
ingestion of leucine. The results indicated that either other amino acids might be 
stimulating insulin secretion or that the combination of leucine with other amino acids 
was responsible for these results. Floyd, Fajans, Conn, Knopf, and Rull (1966) prepared 
a solution containing 10 essential amino acids given in 30 gram increments (arginine, 
lysine, phenylalanine, leucine, valine, methionine, histidine, isoleucine, threonine, and 
tryptophan) to further test Fajan et al.’s (1964) hypothesis. To determine if other amino 
acids could cause insulin secretion, leucine and isoleucine were removed from the 
mixture and the plasma insulin response was measured. From these studies, Floyd et al. 
(1966) found that insulin release could be stimulated in the absence of leucine. The 
response of individual amino acids on insulin secretion was then determined by the 
administration o f 30 gram doses of each of the following amino acids: arginine, lysine, 
phenylalanine, leucine, valine, methionine, and histidine. Arginine was found to be the 
most potent stimulator of insulin secretion followed by lysine, leucine and phenylalanine, 
and valine and methionine. Conversely, histidine did not cause an increase in plasma 
insulin levels. Finally, amino acids do not stimulate insulin release by the same 
mechanism. Floyd et al. (1968) showed that diazoxide and trichloromethiazide inhibited 
the insulin stimulating action o f leucine, but not the action of arginine.
To determine the effects of amino acids in combination with glucose on insulin 
secretion, Rabinowitz, Merimee, Maffezzoli, and Burgess (1966) administered a meal 
containing 64 g of protein and 100 g of glucose. Ingestion o f this meal was followed by a 
very large rise in plasma insulin that exceeded 100 pU per ml. This value is greater than
12
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the sum of the individual responses o f glucose and amino acids and suggests synergism 
between the two substrates. Floyd et al. (1970) further demonstrated a synergistie effect 
on insulin by administering intravenous arginine with glucose which was confirmed by 
Nuttall, Mooradian, Gannon, Billington, and Krezowski (1984). Van Loon, Saris, 
Verhagen, and Wagenmakers (2000) sought to describe the type, combination and 
quantity o f free amino acid required in combination with carbohydrate to maximize the 
synergistic insulin response. The results indicated that a drink containing carbohydrates 
and a mixture of free leucine, phenylalanine, and a wheat protein hydrolysate produced 
the largest rise in plasma insulin. Calbet and MacLean (2002) showed that oligopeptides 
combined with glucose resulted in a greater insulin response than whole proteins or free 
amino acids. However, recent studies have sought to administer more physiological 
levels of arginine. Gannon et al. (1992) used 1 mmol/kg of lean body mass, which 
corresponds to the concentration o f arginine in 1.7 pounds of beef and found that an 
increase in plasma arginine of 27 to 64%, from the protein or the protein plus glucose 
meal, was not effective in stimulating insulin secretion. However, these results do not 
rule out the contribution of other amino acids absorbed with arginine in stimulating the 
insulin response. In fact, the results indicate that the meal might have actually stimulated 
more insulin secretion, which could have resulted in increased extraction by the liver. 
Finally, it was suggested that the amount o f arginine likely found in a high protein meal 
does not stimulate insulin secretion but actually attenuates the glucose response when the 
meal is served with a carbohydrate source. The mechanism by which arginine and 
glucose in combination raise serum glucose remains undetermined. Future studies will 
need to be conducted before this data can be fully validated.
13
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Glucose Tolerance
Prior to 1979, there had been much controversy surrounding the diagnosis criteria for 
impaired glucose tolerance (IGT) and non-insulin dependent diabetes (type 2). In 
addition, the method in which patients were diagnosed with these conditions was 
questionable. In order to clearly define the categories and methodology, the National 
Diabetes Group of the National Institute of Health proposed a classification system that 
was approved by the World Health Organization and the American Diabetes Association 
(1995). Otber international bodies have since recognized these distinetions as well. In 
addition, an Expert Committee of international members was established under the 
American Diabetes Association to continually review and update the findings from the 
original 1979 report (American Diabetes Association, 1995).
According to the American Diabetes Association (2005), glucose tolerance can be 
measured by the oral glucose tolerance test (OGTT) and fasting plasma glucose values. 
Typically, a fasting venous plasma test would be administered to determine glucose 
tolerance as this method is less costly and more convenient than the OGTT. A fasting 
venous plasma value o f less than 115 mg/dl or a two hour postload glucose of 140 mg/dl 
or less would be classified as glucose tolerant. Thus, glucose tolerance has been defined 
as the secretion of normal amounts of insulin in response to oral and intravenous glucose 
loads (Ericksson et ah, 1989).
The report issued in 2005 by the American Diabetes Association identifies 
individuals with impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) as 
those persons who have plasma glucose levels between normal and diabetic. These 
patients are typically referred to as pre-diabetic, although it must be remembered that IGT
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and IFG are not clinical entities but rather risk factors for future diabetes development. 
Diagnosis is based on the oral glucose toleranee test after the plasma fasting glucose level 
is found to be greater than 100 mg/dl but less than 126 mg/dl. Venous plasma results at 
the end of the two hour OGTT of values from 140 to 200 mg/dl would then indicate 
impaired glucose tolerance. Factors associated with an increased risk of developing IGT 
include obesity, increasing age, family history of diabetes, specific racial and ethnic 
groups, a history o f IGT or gestational diabetes, and blood lipid abnormalities (Edelstein 
et al., 1997). Since IGT is considered to be the most important risk factor in the 
development o f type 2 diabetes, early diagnosis is essential. Furthermore, IGT and IFG 
are also risk factors for future cardiovascular disease and are associated with the 
metabolic syndrome, which includes visceral obesity, insulin resistance, compensatory 
hyperinsulinemia, decrease in HDL cholesterol, increase in triglycerides, and 
hypertension (Reaven, 1988).
Impaired glucose tolerance is characterized by resistance to insulin stimulated glucose 
uptake (Reaven, 1988). Tbese individuals have high circulating insulin levels and it is 
noted that obesity exaggerates the condition by increasing insulin resistance. Insulin 
resistance is technically defined as the inability to respond appropriately to insulin, which 
includes the stimulation of glucose uptake and restraining hepatic glucose production 
(Hoffman, 2002). The pancreas responds normally and appropriately in subjects with 
impaired glucose intolerance as there is no evidence of beta cell secretory defects 
(Lillioja et al., 1988). Diabetes typically develops from IGT when the pancreas fails to 
increase the insulin output appropriately and/or the insulin secretion is ineffective in 
removing enough glucose from the bloodstream. Thus, it is thought that diet plays a key
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role in the onset of insulin resistance in IGT since the beta cells appear to function 
normally.
The American Diabetes Association (2005) recommends three ways to diagnose 
diabetes mellitus. This suggestion met the need to create a standardization of diagnosis 
within the medical community. The first method to diagnose non-insulin dependent 
diabetes should be based on the “classical” symptoms of diabetes (polyuria, polydipsia, 
ketonuria, and rapid weight loss) in eombination with casual plasma glucose 
concentration in excess of 200 mg/dl. The second method entails a fasting plasma 
glucose value of 126 mg/dl or more. Finally, a plasma glucose concentration in excess of 
200 mg/dl after an OGTT is a positive diagnosis for type 2 diabetes.
Type 2 diabetes can range from insulin resistance with relative insulin deficiency to 
an insulin secretory defect with insulin resistance. The reason for this range is likely 
because there are many cause o f this chronic disease; all of which have yet to be 
identified. It is thought to be a genetically predisposed condition; however the specifics 
o f this link are not clear at the present time.
Typically, the primary problem in type 2 diabetes is a resistance to insulin by the 
skeletal muscle and to a lesser extent, the liver. Insulin resistance is defined as the 
inability to respond appropriately to insulin and occurs due to reduced responsiveness or 
sensitivity to the hormone, resulting from a combination of receptor and postrecptor 
defects (Hoffman, 2002). The receptor defect results from reduced GLUT4 insulin 
receptors on the target tissue and the postreceptor defect involves a decline in glucose 
transport activity. The receptor defect typically leads to a form of mild insulin resistance; 
however, the addition of the postreceptor defect is what is most commonly associated
16
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with the development o f type 2 diabetes. The exact cause of insulin resistance has yet to 
be identified, but it is often linked with obesity. It is not clear if  the receptor defect is the 
cause of insulin resistance or is a consequence of the insulin resistance (Hansen et al., 
1998). Conversely, not all obese persons will develop insulin resistance (Hoffman,
2002). Others have postulated that an increased supply of free fatty acids to skeletal 
muscle decreases glucose transport and glucose disposal, thereby creating a so-called 
substrate competition (Feskens, 1992).
Type 2 diabetic patients vary in their production of insulin by the pancreas. Impaired 
insulin secretion is a component in the etiology of type 2 diabetes and is caused by a 
defect in the pancreatic beta cells to compensate for the insulin resistance. Therefore, 
glucose-mediated insulin secretion is largely depressed in type 2 diabetics. Furthermore, 
the ability to stimulate insulin secretion from non-glucose stimuli, such as amino acids, is 
also depressed as is the maximal capacity for insulin secretion (Olefsky, 1985).
Another problem that plagues some patients with type 2 diabetes is increased basal 
hepatic glucose production. It is noted that the greater the fasting hyperglycemia, the 
greater the hepatic glucose output (Kolterman et al., 1981). It has been suggested that the 
hormone glucagon may be responsible for the stimulation and that hepatic insulin 
resistance may exaggerate this effect (Lllenquist et al., 1977). Sustained gluconeogenesis 
and free fatty acids may provide the necessary components to allow for the increased 
basal hepatic glucose production to occur in type 2 diabetes (Olefsky, 1985). The 
resulting hyperinsulinemia could potentially cause further insulin resistance by down- 
regulation of the receptors (Feskens, 1992).
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Peripheral insulin resistance, impaired insulin secretion and increased hepatic glucose 
production all result in hyperglycemia. Fasting hyperglycemia is attributed to glucose 
overproduction by the liver, whereas postprandial hyperglycemia is due to inadequate 
glucose uptake by peripheral tissues (Olefsky, 1985). It is unknown whether insulin 
resistance or impaired insulin secretion occurs first or if  they may occur simultaneously. 
Thus, it is clear that more research needs to be conducted in the areas of type 2 diabetes, 
insulin resistance, and glucose tolerance.
Macronutrient Effects on Glucose Tolerance 
The rate o f insulin secretion following a meal will largely be determined by the 
macronutrient composition and the resulting exposure of the beta cells o f the pancreas to 
glucose. In the fasting state, glucose concentration ranges from 70 to 100 mg/dl. After a 
meal containing carbohydrates, this value tends to increase up to 140 mg/dl and then falls 
back to fasting values within approximately two hours (Kreutler & Czajka-Narins, 1987). 
However, insulin’s rate of return to fasting values is much slower and this phenomenon 
has never been fully explained (Nutall & Gannon, 1991).
Carbohydrates
High carbohydrate diets have been recommended as a means to increase insulin 
sensitivity and glucose tolerance in normal subjects since the work of Himsworth in 
1935. This relationship was shown by Kolterman et al. (1979) who demonstrated that a 
high carbohydrate diet fed to normal subjects could reduce plasma glucose levels, despite 
infusions of combined glucose and insulin. Recent studies, however, have reported 
conflicting evidence as many researchers state that insulin sensitivity and glucose
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tolerance can only be achieved if  the diet contains 75 to 85% carbohydrates (Garg, 
Grundy, & Koffler, 1992). Garg et al. (1992) and Borkman et al.(1991) believe this 
content may be too high for most normal dieters to achieve and is therefore an unrealistic 
option. Conversely, a low carbohydrate diet has been shown to lead to an improvement 
in insulin sensitivity in glucose intolerant patients (Parillo et al., 1992). The mechanism 
for improved insulin sensitivity with low carbohydrate diets is unclear. Thus, the 
research on carbohydrate diets on glucose metabolism remains ill-defined until more 
studies are conducted.
Studies on refined sugars and their relationship to the development of diabetes has 
also been a controversial topic as the findings have been inconclusive. Thus, researchers 
such as Kreutler and Czajka-Narins (1987) note the necessity in counseling patients as to 
the type of carbohydrates to be consumed, as it is possible that sucrose and glucose could 
be related to disease development. Foods containing starch however, have been studied 
and more is known about their effects on glucose metabolism. For instance, the glycémie 
index, which is a measure of the rise in blood glucose over a specified period of time 
(typically two hours), varies for starchy food depending upon its water-soluble fiber 
content (Feskens, 1992). Soluble fibers, such as guar and pectin, may aid in glucose 
metabolism possibly by delaying gastric emptying or through gastrointestinal hormone 
secretion of glucagon-like polypeptide-1 and amylin (Fesken, 1992).
Fat
A  meal consisting only of triglycerides will not effect glucose concentration or 
stimulate insulin secretion (Nutall & Gannon, 1991). However, it has been noted for 
several decades that higher rates of diabetes are often associated with diets high in fat.
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One thought is that these diets contain higher caloric and sucrose intake while containing 
less complex carbohydrate sources. However, Collier and O’Dea (1983) have shown that 
fat intake, independent of obesity or body fat, may affect insulin sensitivity and hepatic 
glucose production. The mechanism for this finding was that the large increase in 
triglycerides, which resulted in increased fat oxidation and a decrease in the glucose fatty 
acid cycle, thereby depressing glucose uptake. Hansen et al. (1998) argues that a high fat 
diet in rats will result in insulin resistance due to a decrease in the number of GLUT4 
transporters at the cell surface.
Glucose metabolism is also influenced by the type of fatty acids consumed in the diet. 
Feskens (1992) reports that glucose tolerance was adversely affected by saturated fatty 
acids, while beneficial effects were seen with mono-and polyunsaturated fatty acids. 
Pelikanova, Kohout, Valek, Base, and Kazdova (1989) found that insulin secretion was 
inversely related to the ratio of polyunsaturated to saturated fatty acids in phospholipids. 
Studies conducted on populations that consume large amounts of marine fish and 
mammals, such as the Alaskan Eskimos, have led researchers to postulate the role that 
omega-3 polyunsaturated fats may play in glucose metabolism as these groups have 
astonishingly low prevalence rates of type 2 diabetes (Mouratoff, Carroll, & Scot, 1969). 
It is now thought that this fatty acid enhances glucose clearance by decreasing the 
synthesis of VLDL cholesterol (Feskens, 1992).
Protein
The recent popularity of high protein diets can be seen in the explosion of new diet 
books that are hitting bookstores every week. The first recorded high protein diet was 
described in 1882 by William Harvey in his book. On Corpulence in Relation to Disease.
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It would later be renamed the Banting diet after Harvey’s first patient, who lost 46 
pounds in one year while following the diet. Variants o f this diet were seen beginning in 
the 1950s with Pennington’s Treatment o f  Obesity with Calorically Unrestricted Diets 
and The Air Force Diet in 1960. In 1967, Stilman and Baker published another high 
protein diet book titled The Doctor’s Quick Weight Loss Diet. Arguably, the most 
popular o f all the high protein diet proponents was cardiologist. Dr. Robert Atkins, who 
published his first book Dr. Atkins Diet Revolution in 1972 with updates in 1992 and then 
again in 2002. The Atkins diet has regained popularity with the public, along with other 
current high protein diets such as Protein Power, The Zone, Sugar Busters, The South 
Beach Diet, and The Stillman Diet. This trend has spawned researchers in the public 
health domain to investigate the acute and long-term safety of these diets, while the 
public often appears to be interested in only the issue of efficacy in terms of weight loss.
Any shift in the macronutrient content of the diet will result in a compensatory 
change in the other macronutrients of the diet. High protein diets range in intakes from 
28 to 64% of total energy, which is 71 to 162 g/day (St. Jeor et ah, 2001). This results in 
a decline of carbohydrates ranging from 3 to 16% of total energy, which limits daily 
intake to 7 to 56 g/day (St. Jeor et al., 2001). Ingested protein does not tend to raise the 
plasma glucose concentration in normal subjects. Despite this fact, a protein meal does 
result in increased levels of insulin. The increase in insulin is variable and depends on 
the amino acid composition, quantity and whether the protein meal is eaten in 
combination with carbohydrates. However, the rise in insulin from the protein meal is 
less than that which occurs when carbohydrates are consumed. It is thought that the 
dramatic rise in insulin following a meal is likely caused by the presence of protein.
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amino acids, or fat in the duodenum, which will cause the release of an insulin 
secretagogue, possibly gastric inhibitory polypeptide, from the gut that acts 
synergistically with glucose and amino acids to stimulate the beta cells of the pancreas to 
secrete insulin (Nuttall, Garmon, Wald, & Ahmed, 1985).
Studies have just recently begun to consider the effects of a high protein diet on 
glucose metabolism in humans. Farnsworth et al. (2003) notes that subjects on a 27% 
protein, 44% carbohydrate and 29% fat diet for 16 weeks had less glycémie response than 
subjects on a standard 16% protein diet. Linn et al. (2000) found that protein intake 
increased pancreatic sensitivity to glucose by 15%. As this study was conducted over a 
six month period, the results suggest that a high protein diet could potentially have long­
term effects on glucose metabolism. Despite the rise in serum insulin levels to 516 + 45 
pmol/1, Linn et al. (2000) noted a reduction in glucose oxidation and an increase in 
hepatic glucose production following a high protein diet, which resulted in insulin 
resistance and glucose intolerance. These findings were confirmed by Anderson, Konz, 
and Jenkins (2000) who noted insulin resistance among patient consuming a high protein 
diet, likely the result o f carbohydrate deprivation. Conversely, a 12 month study by 
Foster et al. (2003) showed that a high protein diet and a conventional diet both improved 
insulin sensitivity. However, it should be noted that this result was not independent of 
weight loss. Golay, Ligenheer et al. (1996) suggested that the improvement in insulin 
sensitivity seen in subjects consuming a high protein diet was due to higher levels of 
monounsaturated fat in the diet. Parillo et al. (1992) showed an improvement in insulin 
sensitivity in type 2  diabetics who had consumed a diet that was high in monounsaturated 
fats and low in carbohydrates. However, other researchers such as Borkman et al. (1991)
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and Nestel et al. (1984) have been unable to show any improvements in insulin sensitivity 
on similar diets high in monounsaturated fats.
Researchers such as Nutall and Gannon (1991) have begun to ponder the effects of 
high protein diets in the management of type 2  diabetes because o f the known synergistic 
effects o f protein with glucose in stimulating insulin secretion. Nutall and Gannon 
(1991) have shown that protein ingestion by type 2  diabetics may lead to a decrease in 
postprandial glucose concentrations. A subsequent study by Gannon and Nuttall (2004) 
in uncontrolled type 2 diabetics showed that a 20% carbohydrate, 30% protein and 50% 
fat diet resulted in decreased circulating glucose concentrations and serum insulin levels 
over a five week period. Thus, a high protein low carbohydrate diet may have clinical 
applications for treating hyperglycemia without pharmacological intervention; however 
the long-term effects of this diet have not been identified.
Clinical investigations of weight loss achieved and maintained on high protein diets 
have shown conflicting results (Foster et al., 2003). Reasons suggested for the 
inconsistent data include the following: obese subjects compared to normal weight 
individuals, short uncontrolled trial periods, and non-specific directions given to 
participants. However, when the majority of weight loss data on high protein diets is 
examined a pattern does emerge. It appears that among most types o f subjects in the first 
three to six months o f initial dieting, the weight loss is typically double (7.7 kg vs. 3.6 
kg) compared to individuals on conventional low fat, low calorie diets (Golay, Allaz, et 
ah, 1996 and Foster et ah, 2003). However, the weight loss at 12 months is apparently 
similar and insignificant in both groups (Foster et ah, 2003 and Stem et ah, 2004). 
Furthermore, Golay, Allaz et ah (1996) and St. Jeor et ah (2001) who have investigated
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weight loss on high protein diets, conclude that weight loss or decreased adipose tissue 
mass is not influenced by the composition of a hypocaloric diet.
Due to the recent popularity o f the high protein diet, there have been several 
independent studies on variations of the diet, mainly concerned with the aspect of weight 
loss. An initial study by Due, Toubro, Skov, and Astrup (2004) showed that an ad 
libitum, fat-reduced, high protein diet resulted in greater weight loss over a six month 
period than a medium protein diet (9.4 kg vs. 5.9 kg). However at 12 months, no 
significant difference could be seen between the two diet groups. At 24 months, both 
groups tended to maintain their 12 month weight loss, which was between 4.3 and 6.2 kg, 
however more than 50% of subjects had dropped out of the study since its inception. 
Farnsworth et al. (2003) compared a high protein diet (27% energy from protein, 44% 
from carbohydrates and 29% from fat) to a standard protein diet (16% protein, 57% 
carbohydrate and 27% fat) in 57 overweight subjects for 16 weeks and found that weight 
and fat loss did not differ between the two groups (7.9 + 0.5 kg and 6.9 + 0.4 
respectively). Foster et al. (2003) compared a high protein, high fat low carbohydrate 
diet to the conventional diet recommended by the U.S. Department o f Agriculture. Sixty- 
three obese subjects were involved in the 1 2  month study that attempted to replicate the 
popular Atkins diet. At 3 and 6  months, the high protein group had lost more weight, but 
at 12 months, there was no significant difference between the groups. Foster et al. (2003) 
suggests that the lack of difference between groups at 1 2  months is likely due to greater 
weight regain, as the high protein diet may be difficult to adhere to for long periods of 
time. As with other studies (Schoeller, 1990), Foster et al. (2003) noted that compliance 
was poor and only 59% of subjects completed the entire protocol.
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Most short-term studies of high protein diets suggest that weight loss occurs as a 
result of protein’s powerful effect on satiety and through the increase in total energy 
expenditure by an increase in the thermic effect o f feeding (Eisenstein, Roberts, Dallai,
& Saltzman, 2002). However, when energy intake is fixed in these short-term studies no 
difference is noted in weight or fat loss. Eisenstein et al. (2002) does speculate that an ad 
libitum intake of high protein diets will likely result in a greater decrease in energy intake 
and therefore a greater weight loss during short-term studies. This has been demonstrated 
by investigators such as Due et al. (2004) and Foster et al. (2003).
St. Jeor et al. (2001) attributes the initial weight loss that occurs on a high protein diet 
to the diuretic effect of a low carbohydrate intake and the resultant glycogen depletion. 
Anderson et al. (2000) notes that glycogen is hydrated with approximately 2 to 3 grams 
of water and that high protein low carbohydrate diets will quickly deplete muscle and 
liver glycogen, resulting in rapid water loss from the body. Furthermore, serum insulin 
levels are decreased which contributes to greater water loss as insulin typically promotes 
water retention (Anderson et al., 2000). As the diet is continued, appetite is further 
suppressed by ketosis, the strict eating plan and schedule, and a limited tolerance for high 
protein foods (St. Jeor et al., 2001). Furthermore, eliminating carbohydrates from the diet 
makes overeating problematic. Carbohydrates are a major macronutrient and typically 
comprise a large portion of mixed meals (Coyle, 2004). The overall suppression of 
appetite results in reduced caloric intake, which will cause weight loss. Thus, any weight 
loss achieved on a high protein diet is due to the principles that physiologists have known 
all along -  caloric expenditure must be greater than caloric intake.
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Calorie restriction, without physical activity, can result in the loss of lean body mass 
(Pavlou, Steffe, Lerman, & Burrows, 1985). Some researchers have speculated that high 
protein dieters avoid this effect because ketone bodies may spare lean tissue (Pawan and 
Semple, 1983). Piatti et al. (1994) examined subjects on a high protein diet and noted 
that lean body mass was spared. They compared their results to subjects consuming a 
high carbohydrate, high fiber diet and reported that lean body weight was decreased in 
this group. They speculate that preservation of lean body mass on a high protein diet can 
be attributed to an inhibitory effect of protein on proteolysis on fat free mass. Hoffer et 
al. (1984) previously described this effect and found that 1.5 g protein/kg ideal body 
weight is the minimal intake required in order to adequately maintain whole-body 
nitrogen turnover at pre-diet levels. However, others investigators have shown no 
difference in sparing o f lean body weight on high protein diets or even less protein 
sparing (Vasquez and Adibi, 1992). The reason for the disparity in results may include 
the difference in calories and protein composition of the diets and the short duration of 
clinical investigations. Thus, more research needs to be conducted on the issue of lean 
body weight preservation during the use of high protein diets.
The long-term health effects of high protein diets have not been fully identified. 
Despite the fact that these diets have existed in some form since 1882, in depth research 
has just recently begun. Consumption of protein greater than two to three times the U.S. 
Recommended Daily Allowance (.80 g/kg o f body weight) has been shown to contribute 
to urinary calcium loss (Anderson et ah, 2000), which has clear implications for bone loss 
and the development of osteoporosis. In addition, individuals with kidney disease are 
advised against undertaking a high protein diet (Eisenstein et al., 2002) due to the
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increased workload placed on the kidneys to breakdown the extra proteins. Furthermore, 
physicians have been wary to prescribe a high protein diet as a treatment method for 
hyperglycemia o f type 2  diabetics as this diet may speed up the progression o f renal 
disease and promote greater yet unidentified complications (Eisenstein et al., 2002). 
Purines, which are broken down into uric acid, are found in high protein foods such as 
animal meats, eggs, seeds and nuts. Increased levels of uric acid in the body from these 
diets are associated with the development of gout. High protein diets typically promote 
the consumption o f animal proteins, which have been linked to an increase in low-density 
lipoproteins (Larosa, Fry, Muesing, & Rosing, 1980). The elimination of high-fiber fruits 
and vegetables may also raise the risk of increased LDL cholesterol and increase blood 
pressure through the elimination of potassium, calcium, and magnesium with the 
concurrent increase in sodium (St. Jeor et ah, 2001). In addition, the elimination of high 
fiber fruits and vegetables may also increase the risk for certain cancers (St. Jeor et al., 
2001). As many healthy foods such as fruits, vegetables and cereals are restricted on 
high protein diets, it is likely that long-term adherence could lead to vitamin and mineral 
deficiencies which may lead to future adverse health effects.
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CHAPTER 3
METHODS
Subjects
Twenty adult female Sprague Dawley rats were obtained from the Charles River 
(Hollister, CA) at 45 to 56 days of age. All rats weighed approximately 125 toi 50 grams. 
The experiment was approved and followed by the guidelines issued by the Institutional 
Animal Care and Use Committee at the University o f Nevada, Las Vegas.
Experimental Protocol
All rats were housed individually in a controlled environment (22-24°C with 12 hour 
light and dark cycles). The rats were fed a standard chow diet (60% carbohydrate, 28% 
protein, 12% fat) (Purina Mills Inc. 5001, Richmond, IN) for a period of three days. The 
rats were then divided into two groups with equivalent body weights. The control group 
was maintained on the standard diet for eight weeks. The experimental group was fed a 
high protein diet (65% protein, 35% fat) (Harlan Teklad TD.04487, Madison, WI) during 
the same eight weeks. Food and water were provided ad libitum. Rats were weighed 
weekly.
At the end of the third week, all rats underwent an oral glucose tolerance test (Balon, 
Jasman, and Young, 1999). Following an overnight fast, rats were weighed and a 
baseline blood sample (300pl) was collected by tail bleeding. Rats were administered 2-
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g/kg body wt of a 50% dextrose solution by gavage. Blood (300gl) was collected in 
microcapillary tubes at 0, 15, 30, 60, and 120 minutes for the measurement of blood 
glucose and plasma insulin. Plasma was separated by centrifugation and stores at -80  °C. 
Blood glucose was measured by a glucose meter (One Touch Basic, Lifescan Inc, 
Milpitas, CA). Plasma insulin concentration was measured via radioimmunoassay 
(Linco, St. Charles, MO). Following the oral glucose tolerance test, animals were 
returned to their cage.
At the end of the seventh week, the oral glucose tolerance test was repeated. Rats 
were then euthanized by intracardial injection of sodium pentobarbital (5mg/100g of 
body weight) at the end of the eighth week. The ovarian fat pads, soleus and extensor 
digitorum longus muscles were surgically removed and weighed.
Data Reduction
Blood glucose, measured in mg/dl, was recorded at baseline, 15, 30, 60 and 120 
minutes during each of the oral glucose tolerance tests. Plasma insulin was measured in 
ng/ml for the same time intervals during the oral glucose tolerance tests. Total area under 
the concentration curves for blood glucose and plasma insulin was calculated using the 
trapezoid method.
Statistical Analysis
The fwo levels of the independent variable were the control diet and the high protein 
diet. The dependent variables were the area under the glucose and insulin concentration 
curves. The mean and standard deviation for the area under each concentration curve
29
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
was calculated for both groups. The mean and standard deviation at each time point for 
blood glucose and plasma insulin was also calculated. A 2 X 2 mixed model ANOVA 
was used to determine if  the effects of the diet were independent of the effects of growth 
for area under the glucose and insulin response curves. A 2 X 2 mixed model ANOVA 
was also used to ascertain if  the effects of the diet were independent o f the effects o f time 
on the subject’s body weight. If  interaction was noted in either mixed model ANOVA, 
simple main effects tests were performed and included independent t-tests for the 
between subjects factor and a paired t-test for the repeated measure. A 2 X 5 mixed 
model ANOVA was employed to distinguish if  the effects o f the diet were independent of 
time on blood glucose and plasma insulin concentrations, respectively. If  interaction was 
noted in the 2 X 5  mixed model ANOVA, simple main effects tests were performed and 
included independent t-tests for the between subjects factor and a repeated measures 
ANOVA for the repeated measure.
An independent t-test was used to determine if differences existed in the ovarian fat 
pad weights between groups. Independent t-tests were also used to determine if 
differences existed in the weight o f the soleus muscle and the weight o f the extensor 
digitorum longus between the control and high protein diet groups, respectively. When 
group variances were not equal in the independent t-tests, Levene’s tests were performed.
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CHAPTER 4 
RESULTS
The data for one animal from the control group was removed from analysis when it 
was determined that it was a male Sprague Dawley rat. In addition, data for one animal 
from each group was eliminated because of spurious values.
There was no interaction between initial and final weight and diet on the influence of 
body weight (Fi, 15 = 1.0924, p = .3125); therefore the main effects were examined 
independently. The main effect for diet was not significant (F]_ 15 = 1.7892, p = .2010). 
The main effect for time was significant (Fi, 15 = 362.5750, p < .0001). Body weight 
increased to the same extent in each group from the initial to the final weighing. Body 
weight increased from 159 + 2 g to 254 + 7 g in the control group and from 157 + 2 g to 
242 ± 7 g in the protein group (Figure 1). There was no interaction between development 
and diet on the animal’s growth over the course of the study (Fi, 15 = 2.8928, p = .1096) 
(Figure 2). The main effect for diet was significant (Fi, 15 = 5.7892, p = .0295) and 
analysis of the means indicated that the control group had a greater body weight at each 
weighing, although final body weights were not different. The main effect for time was 
also significant (Fg, 1 5 = 283.6136, p <.0001).
There was a significant difference in the weight of the ovarian fat pads between the 
control and high protein diet groups (t = 2.8799, p = .0087), which is shown in Figure 3.
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The control group’s ovarian fat pads weighed significantly more than the fat pads of the 
experimental group (1.90 + .253 g vs. 1.11 + .106 g). There was no significant difference 
in the weight of the soleus muscle between groups (t = - .1913, p = .4257). There was 
also no difference in the weight of the extensor digitorum longus (EDL) muscle between 
the control and high protein diet group (t = .8297, p = .2099) (Figure 4).
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Figure 1 ; Difference in initial and final body weights in control and protein fed animals. 
* Significantly different from initial body weight, p < 0.05.
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Figure 2: Difference in growth rate between control and protein fed animals. 
* Significantly different from control, p < 0.05.
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Figure 3; Difference in ovarian fat pad weight between control and protein fed animals. 
* Significantly different from control, p < 0.05.
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Figure 4: Difference in hindlimb muscle weight between control and protein fed animals.
There was a significant interaction hetween growth and diet on the area under the 
glucose concentration curve (Fi_ 15 = 5.0071, p = .0408). Simple main effects analysis 
revealed that there was a significant increase in area under the glucose concentration 
curve in the protein group from the first to the second OGTT [(t = -2.2222, p = .0285) 
(9846 + 300.4 mg/dl/120 min vs. 10721 + 438.2 mg/dl/120 min)] hut no significant 
differences were noted in the control group [(t = .8210, p = .2194) (10357 + 293.7 
mg/dl/120 min vs. 10134 + 395.3 mg/dl/120 min)]. Area under the curve is depicted 
graphically in Figure 5. During the first OGTT, there was no difference in area under the 
curve hetween the control and high protein diet groups (t = 1.2095, p = .1226). There 
was also no difference in area under the glucose concentration curve between the two 
groups during the second OGTT (t = -.9855, p = .1700).
During the first OGTT (Figure 6 ), there was a significant interaction between time 
and diet on blood glucose concentrations (F 4 , 6 0 = 5.0002, p = .0015). Simple main 
effects analysis showed that there was a significant difference between the control and
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high protein diet groups at 30 minutes (t = 3.3486, p = .0022), 60 minutes (t = - 1.7948, p 
= .0465), and 120 minutes (t = 1.9713, p = .0337). During the second OGTT (Figure 7), 
there was a significant interaction between time and diet on blood glucose concentrations 
(F4 , 60 = 8.0553, p <.0001). Simple main effects analysis showed that hlood glucose was 
significantly different hetween the control and high protein diet groups at 15 minutes (t = 
3.1863, p = .0031), 60 minutes (t = -1.7532, p = .0522) and 120 minutes (t = -3.8465, p = 
.0008^
Area Under the Glucose Concentration Curve
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Figure 5: Difference in area under the glucose concentration curve between control and 
protein fed animals in OGTT 1 and OGTT 2. * Significantly different from OGTT 1,
p < 0.05.
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Glucose Response to Oral Glucose Challenge 1
140
^  120 
1  100 
&  80 
S 60o
3  40
O
15 30 600 120
— Control 
-A— Protein
Time (min)
Figure 6 : Difference in glucose response between control and protein fed animals in 
OGTT 1. * Significantly different from control, p < 0.05.
Glucose Response to Oral Glucose Challenge 2
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Figure 7 : Difference in glucose response between control and protein fed animals in 
OGTT 2. * Significantly different from control, p < 0.05.
There was no interaction between growth and diet (Fi_ 15 = .0242, p = .8785) on the 
area under the insulin concentration curve; therefore the main effects were examined 
independently. The main effect for diet was not significant (F,_ 15 = .1488, p = .7051).
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The main effect for time was significant (F ijs  = 18.0580, p = .0007) and analysis o f the 
means revealed that the area under the insulin concentration curve increased from the 
first to the second OGTT (45.2615 + 6.7116 ng/ml/120 min vs. 94.5835 + 10.9204 
ng/ml/120 min). Area under the curve is illustrated in Figure 8 . During the first OGTT, 
there was no difference in area under the insulin concentration curve between the control 
and high protein diet groups (t = .5425, p = .2978). There was also no difference between 
groups in area under the curve during the second OGTT (t = .1709, p -  .4333).
During the first OGTT (Figure 9), there was a significant interaction between time 
and diet on plasma insulin concentrations (F4 , 6 0  = 2.4496, p = .0557). Simple main 
effects analysis revealed there was a significant difference between the control and 
protein diet group at 30 minutes (t = 1.9521, p = .0414) and 120 minutes (t = -2.0027, p = 
.0388). The second OGTT (Figure 10) indicated no interaction between time and diet on 
plasma insulin concentrations (F4 _ 6 0 = 1.6953, p = .1629). The effects of diet (Fi, 15 = 
.1300, p = .7234) and time (F4 _ 6 0  = 2.0726 p = .0956), which were examined 
independently, were also not significant.
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Area Under the Insulin Concentration Curve
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Figure 8 : Difference in area under the insulin concentration curve between control and 
protein fed animals in OGTT 1 and OGTT 2. * Significantly different from OGTT 1,
p < 0.05.
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Figure 9: Difference in insulin response between control and protein fed animals in 
OGTT 1. * Significantly different from control, p < 0.05.
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Figure 10: Difference in insulin response between control and protein fed animals in
OGTT 2.
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CHAPTER 5
DISCUSSION AND RECOMMENDATIONS 
Discussion of Results 
The primary interest of this study was to determine if a long-term high protein diet 
has adverse effects on glucose tolerance in normal adult female Sprague Dawley rats. 
Unlike the results of other similar investigations conducted in humans (Anderson et ah, 
2000 and Linn et ah, 2000), glucose tolerance and the insulin stimulated response to an 
oral glucose load were not affected by a high protein diet.
During the rat’s developmental process, the weight of the control group tended to be 
higher (14 + 2 g) than that of the experimental group. However, by the completion of the 
study, there was no significant difference in the adult animal’s body weight between the 
control and high protein diet groups (254 ± 7 g and 242 + 7 g). This is in accordance 
with many dietary interventions, particularly high protein protocols, as weight loss is 
typically increased in the short-term and insignificant by the program’s completion 
(Foster et al., 2003; Stem et al., 2004; Golay, Allaz et al.,1996 and St. Jeor et al., 2001). 
One possible explanation for the initial weight loss is glycogen depletion caused by the 
diuretic effect of a high protein diet (St. Jeor et al., 2001). Diets lacking carbohydrates
40
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will quickly deplete the supply o f glycogen in skeletal muscle and liver, as glycogen is 
hydrated with approximately 2 to 3 grams of water (Anderson et ah, 2000). Insulin 
promotes water retention and high protein diets decrease serum insulin levels, leading to 
further body water loss (Anderson et al., 2000).
Despite similar body weights upon conclusion of the study, the ovarian fat pad 
weights differed significantly between the control and high protein diet groups (1.9043 ± 
.2529 g and 1.1148 + .1058 g). Ovarian fat pads have shown to play a role in the thermic 
effect of feeding of small rodents via an uncoupling protein (UCP) which exhibits the 
chemical and morphological characteristics of brown adipose tissue (Cousin et al., 1992). 
Brown adipose tissue (BAT) thermo genesis has been linked to energy balance by 
experimental investigations of obesity which show reduced UCP mRNA in obese Zucker 
rats (Cousin et al., 1992). A diet high in protein and free of carbohydrates has been 
linked to a decrease in BAT thermogenesis and a reduction in lipogenesis, most likely 
resulting from hypothalamic mediated suppression of key neural and hormonal signals 
(Moura et al., 2001). However, rats fed a high protein diet are subject to increased levels 
of glucagon and lowered levels o f insulin. Moura et al. (2001) does acknowledge that 
because insulin stimulates BAT lipogenesis, it is possible that a low insulin to glucagon 
ratio at the level of the tissue could lead to a reduction in fatty acid synthesis.
Dietary interventions have important ramifications on BAT thermogensis. Moura et 
al. (2 0 0 1 ) noted that despite similar body weights and energy intake, rats on a high 
protein diet had a notable reduction in BAT tissue weight when compared to a control 
group. Diets high in polyunsaturated fat decrease BAT thermogenesis and lead to lower 
body fat content (Shimomura , Tamura & Suzuki, 1990). As the fat content of the high
41
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
protein diet was primarily polyunsaturated (8 .6 % by weight), this finding also influences 
the notable leanness in the experimental group’s ovarian fat pads. Thus, the reduced 
weight o f the ovarian fat pads noted in the high protein diet group is likely the result of 
the reduction in lipogenesis and the decrease in BAT thermogenesis.
Insulin sensitivity diminished for the control and high protein diet group from the first 
to the second oral glucose tolerance test. The animals were approximately 65 days old (9 
weeks) during the data collection o f the first OGTT and 94 day old (13 weeks) for the 
second test. The area under the insulin concentration curve for the control group was 
49.21 + 8.46 ng/ml/1230 min and 96.63 + 13.68 ng/ml/120 min, respectively. The area 
under the insulin concentration curve for the high protein group was 41.75 +_10.54 
ng/ml/1230 min and 92.77 + 17.44 ng/ml/120 min.
During two critical periods o f growth in the rat, early development (3-5 week) and 
adolescence (5-24 weeks), utilization of glucose notably decreases in skeletal muscle 
(Goodman, Dluz, McElaney, Belur & Ruderman, 1983). This is typically explained hy 
the decrease in the muscle cell’s response to insulin and an overall decrease in insulin 
sensitivity. Olefsky, Bacon and Baur (1976) compared the plasma membranes in skeletal 
muscle o f 6  week old rats to a group o f 36 week old animals and noted that the older rats 
had 30 to 40% fewer insulin binding sites. Goodman et al. (1983) acknowledges that the 
decrease in insulin sensitivity noted in aging rats could he the result o f decreased physical 
activity, increased adiposity, changes in muscle fiher size, and hormonal activity. Thus, 
the most probable explanation for the diminished insulin sensitivity noted in the control 
and high protein diet groups is the decrease in insulin binding sites in skeletal muscle.
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The animals in the high protein diet group displayed a delayed glucose response 
during the first and second OGTT. The peak glucose response during the first OGTT 
occurred at 30 minutes (112 + 7 mg/dl) for the control group and 60 minutes (101 + 5 
mg/dl) for the high protein diet group. The peak glucose response for the second OGTT 
occurred at 15 minutes (117 + 5 mg/dl) in the control group and 60 minutes (95 + 7 
mg/dl) in the experimental group. Bantle et al. (1983) demonstrated that normal 
glycémie subjects reached their peak plasma glucose concentration most frequently at 30 
minutes when consuming mixed meals with 25% of their test carbohydrates as glucose, 
fructose, sucrose, potato starch or wheat starch.
The delayed glucose response in the high protein diet group likely occurred due to the 
process of glucose absorption in the small intestine. Crane (1977) hypothesized that in a 
secondary active absorption process, the Na^ gradient of the intestinal mucosa cells 
allows for the transport of glucose across the brush border membrane (BBM) via the 
transporter SG LTl. This process is powered by the removal o f Na^ from the interior of 
the cell by the Na’^ /K'^  - ATPase of the basolateral membrane. Pappenheimer and Reiss 
(1987) proposed a passive absorption process, paracellular flow, in which the SGLTl- 
mediated transport of glucose into the intercellular space creates an osmotic driving force 
for solvent flow. In this solvent drag theory, the opening of the otherwise tight 
intercellular junction permits bulk absorption of glucose and other nutrients into the cell. 
However, Ferraris and Diamond (1997) have suggested that paracellular flow is 
negligible at best and that the kinetic properties o f SGLTl are sufficient to account for 
the observed rates o f glucose absorption. Furthermore, Ferraris and Diamond (1997) 
state that the capacity o f the BBM transporters is most likely linked to the metabolic
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demands of the small intestine. Recently, Kellett and Helliwell (2000) have showed that 
GLUT2 acts via facilitated diffusion to transport glucose following the active transport 
mechanism of SGLTl.
The hypothesis of Ferraris and Diamond (1997) has important implications for diet 
and glucose transport in the small intestine. For example, changes in glucose transport 
have been noted as quickly as one-half to one day following a switch from a no 
carbohydrate to a high carbohydrate diet, whereas the decline in glucose transporters 
when changing from a high to a low carbohydrate diet takes two to three days (Ferraris & 
Diamond, 1992). The difference has been attributed to the maximal velocity (V^ax) of 
the glucose transporter, independent of any variation in mucosal mass or glucose passive 
permeability, which arises from equal changes in the transporter density (Ferraris & 
Diamond, 1992). They have also suggested that glucose transport is enhanced via an 
increase in the number o f active transporters in the villus, which has been noted in high 
carbohydrate diets (Ferraris, Villenas, Hirayama, & Diamond, 1992). Thus, the delayed 
glucose response of the high protein diet group can be attributed to a decrease in Vmax as 
an agent of a decline in transporter density and a failure to enhance recruitment of active 
transporters in the villus.
Conclusion and Recommendations for Further Study
The recent popularity of high protein diets to aid in weight loss has resulted in an 
explosion of diets on the market that have little to no scientific testing behind their 
claims. Further, the impact of these diets on health has just begun to be explored. As 
rates of type 2 diabetes continue to climb in the United States, the consequences of
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dietary interventions on glucose metabolism are particularly important. In the present 
investigation, it was determined that a high protein diet did not effect glucose tolerance or 
insulin stimulated glucose transport in normal adult female Sprague Dawley rats.
Due to the diverse populations experimenting with high protein diets, future 
investigations should include male subjects to determine the possibility of altered glucose 
metabolism in this group. Furthermore, clinical studies could be extended in duration to 
infer more appropriately the long-term effects o f the diet. It would also be useful to 
further examine the effects of a high protein diet on the blood lipid profile, development 
o f coronary artery disease and the potential impact on bone and renal health.
Alterations in the composition of the experimental diet could also be useful in 
determining the effects of the diet on body composition and potentially glucose 
metabolism. For example, changing the content o f saturated, polyunsaturated and 
monounsaturated fat could influence the results o f future studies. It would also be 
interesting to experiment with diets using various amounts of carbohydrates, as opposed 
to eliminating this macronutrient from the protocol. Finally, further study of the impact 
o f diet on glucose uptake in the small intestine may be critical in better understanding of 
whole-body glucose uptake.
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APPENDIX I
EXPERIMENTAL PROTOCOL
46
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Content of Experimental Diet from Harlan Teklad (Product # TD.04487)
Content 8/Kg
Casein 700T)
Soybean Oil 140.0
Cellulose 12185
Mineral Mix, Ca-P Deficient (TD 79055) 11369
Calcium Carbonate CaCOs 20.0
Niacin 103
Calcium Pantothenate 0.016
Pyridoxine HCl 0.007
Thiamin HCl 1006
Riboflavin 1006
Folic Acid 0.002
Biotin 0.0002
Vitamin B , 2  (0.1% in mannitol) 1025
DL-Alpha Tocopheryl Acetate (500 lU/g) 0H5
Dry Vitamin A Palmitate (500000 U/g) 1008
Vitamin D3 , cholecalciferol (500000 U/g) 0.002
Vitamin K, phylloquinone 0.0008
Choline Bitartrate 2.5
TBHQ (antioxidant) 1028
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Content of Control Diet from Purina Mills Inc (Product #5001) 
60% Carbohydrates, 28% Protein, 12% Fat
Content Percent of Ration (unless otherwise noted)
Arginine 138
Cystine 032
Glycine L20
Histidine 0.55
Isoleucine 1.18
Leucine 1.70
Lysine 1.42
Methionine 143
Phenylalanine 1.03
Tyrosine 0 . 6 8
Threonine 0.91
Tryptophan 129
Valine 1 . 2 1
Serine 1 . 2 1
Aspartic Acid 283
Glutamic Acid 4.54
Alanine 1.44
Prolline 1.55
Taurine 102
Linoleic Acid 1.16
Linolenic Acid 0.07
Arachidonic Acid <101
Omega-3 Fatty Acids 126
Total Saturated Fatty Acids 1.50
Total Monounsaturated Fatty Acids 138
Fiber (Crude) 5.3
Nitrogen-Free Extract (by difference) 419
Starch 3L9
Glucose 123
Fructose 030
Sucrose 338
Lactose L67
Ash 6.9
Calcium .95
Phosphorus .67
Potassium 1 . 1 0
Magnesium 121
Vitamin B | 2 2 2  mcg/kg
Vitamin A 22 lU/gm
Vitamin D 3 4.5 lU/gm
Vitamin E 49IU/kg
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Reference Curve Data
Standard CPM Net CPM % Bound Log % Bound
NSB 316
Bo 4740 4424
0.02 4712 4G96 99 1.996
&05 4509 4193 95 1.977
0 . 1 3886 3570 81 1^W8
0 . 2 2809 2493 56 1.748
0.5 1346 1030 23 1362
1 730 414 9 0.954
Reference Curve
Insulin Assay
2.5
" Oa
9o
CQ
y = -1.0906x + 1.9974 
= 0.9847
DC
J  0.5
0.2 0.60.4 0.8 1.20 1
Insulin (ng/m)l
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APPENDIX II
RAW DATA
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Wei g;ht (g)
Subject 2/25/05 3/3/05 3/11/05 3n7m5 3%^#5 330M5 4/7/05 4/15/05 4/22/05
1 162 175 206 2 0 0 2 1 1 2 1 0 226 241 232
2 159 180 206 214 235 232 270 255 241
3 162 177 185 177 213 2 1 0 227 219 225
4 155 178 198 192 228 234 251 240 253
5 177 231 294 306 378 402 437 448 444
6 154 183 2 1 0 225 272 256 265 273 279
7 156 182 203 196 232 242 252 242 255
8 161 183 2 0 0 190 236 236 261 246 258
9 160 182 196 191 228 229 243 237 238
1 0 167 199 213 2 1 2 252 252 271 279 282
1 1 162 172 186 182 203 209 214 224 228
1 2 149 162 180 186 200 204 230 219 221
13 166 170 203 204 223 234 254 250 264
14 154 178 2 0 0 203 232 246 262 263 273
15 147 161 183 178 207 209 216 227 221
16 166 174 2 0 1 200 219 223 238 245 250
17 150 162 177 179 203 207 217 222 223
18 149 163 177 189 218 236 238 246 253
19 155 171 195 196 214 229 248 251 262
2 0 162 173 191 182 212 217 220 220 232
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Ovarian Fat Pad Weight (g)
Subject Number 4/22/05
1 1.7202
2 1 . 1 2 0 1
3 0.9730
4 2 . 6 6 6 6
5 N/A
6 1.8400
7 2.1327
8 2.1052
9 1.4079
1 0 2.9885
1 1 1.0850
1 2 0.7867
13 1.2557
14 1.6739
15 0.6742
16 1.1890
17 0.8329
18 1 . 1 1 0 2
19 1.4067
2 0 1.1288
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Hindlimb Muscle Weight (g)
Subject Number Soleus Extensor Digitorum Longus
1 0.1449 0.1437
2 0.1360 0.1468
3 0.1150 0.1000
4 Ori388 0.2483
5 (12179 0.1407
6 0.1379 0.1213
7 0.1032 0.0950
8 0.1114 (11082
9 0.1169 0.1270
1 0 0.1379 (11308
1 1 0.1577 01086
1 2 0ri053 0.1030
13 0.0972 0.1107
14 0T567 0.1454
15 01357 0.1150
16 0.1604 (11295
17 (10918 (10953
18 0.1375 0.0947
19 01304 0 . 1 2 0 0
2 0 0.1047 01082
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Glucose Response (mg/dl) to Oral Glucose Challenge 1
Subject 0  min 15 min 30 min 60 min 1 2 0  min AUC
1 53 79 63 40 44 6120
2 73 78 108 95 68 10463
3 68 69 1 0 0 70 78 9285
4 70 74 113 1 0 1 63 10613
5 64 68 103 100 61 10148
6 65 107 106 97 1 0 0 11843
7 57 109 82 90 61 91788
8 52 108 105 94 56 10283
9 53 88 148 69 47 9»563
1 0 59 1 0 2 134 96 57 11018
1 1 62 93 83 105 49 9923
1 2 57 84 79 1 0 1 49 9480
13 61 83 93 107 61 10440
14 59 84 88 105 59 10178
15 62 84 97 107 60 10523
16 63 93 94 99 59 10208
17 62 78 79 63 45 7598
18 55 89 85 72 48 8340
19 59 67 78 116 50 9923
2 0 55 77 96 107 60 10343
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Glucose Response (mg/dl) to Oral Glucose Challenge 2
Subject 0  min 15 min 30 min 60 min 1 2 0  min AUC
1 51 56 51 50 45 5970
2 63 88 98 81 70 9743
3 67 1 2 0 105 81 64 10230
4 81 115 130 89 65 11213
5 57 83 75 55 56 7515
6 73 124 138 89 61 11348
7 55 1 1 1 104 70 57 9278
8 65 113 78 77 68 9443
9 55 128 67 65 54 8385
1 0 79 135 107 97 68 11430
1 1 77 1 1 2 92 65 73 9443
1 2 74 115 107 105 90 12113
13 62 1 0 1 99 1 1 1 102 12263
14 57 96 97 116 82 11730
15 64 96 97 97 90 11168
16 69 78 72 86 6 6 9158
17 63 86 88 70 71 9023
18 59 93 81 77 77 9435
19 6 6 95 91 81 79 9983
2 0 65 93 95 1 2 0 73 11610
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Insulin Response (ng/ml) to Oral Glucose Cha'
Subject 0  min 15 min 30 min 60 min 1 2 0  min AUC
1 1.65 0 . 0 0 0 . 0 0 030 030 0.00
2 038 1.13 032 0.51 036 57.75
3 0.00 032 1.17 030 0 . 0 0 31.13
4 0 . 0 0 0.05 0.46 0.15 034 2535
5 032 0.64 0.09 034 036 6138
6 1.91 L78 2 . 0 1 0.04 0 . 0 1 8835
7 030 3.68 0.24 0 . 0 1 0 . 0 0 6330
8 0 . 0 0 0.34 1 . 1 2 036 0.31 6930
9 (169 0.46 0.00 032 0 . 0 0 2U98
1 0 0.41 1.45 038 0 . 0 1 0 . 1 0 3633
1 1 0.26 0.14 032 039 0.07 3335
1 2 0.46 0.74 &48 030 0.07 27.45
13 0 . 1 1 0 . 0 0 0.16 0 . 0 0 0.00 4.425
14 0.03 &00 0.49 030 0.64 39.45
15 0.76 L87 0.03 038 1.04 6933
16 0.15 0.79 0.09 1.03 1 . 0 0 9135
17 0.00 039 0.00 0 . 0 1 233 77.70
18 0.00 036 233 1.25 036 150.40
19 0.00 030 0 . 0 0 030 038 0.00
2 0 &07 039 0.71 033 031 3330
lenge 1
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Insulin Response (ng/ml) to Oral Glucose Cha:
Subject 0  min 15 min 30 min 60 min 1 2 0  min AUC
1 033 0.17 0 39 035 4.08 161.70
2 232 0.77 03 0 037 032 110.70
3 1 . 1 1 1 . 1 1 037 0.17 034 5265
4 (155 0.96 138 039 0.57 8&48
5 L33 L63 1.09 1.46 (123 131.6
6 037 1.78 245 (167 0.72 136.40
7 030 1.19 0.91 0.49 032 7223
8 0.43 1.37 138 136 (128 151.40
9 039 1 . 1 2 0 . 2 1 (122 037 4345
1 0 (100 233 1.71 (173 (148 117.70
1 1 130 2.36 1.69 (143 2.77 185.60
1 2 0.24 1 . 1 0 0.91 03 4 (148 6848
13 038 0.63 035 0 34 3.69 140.20
14 0.19 (133 0.08 1.45 (189 1 0 0 . 1 0
15 0.13 1.96 2.02 0.55 (187 126.70
16 1.78 1.05 1.54 (127 (178 9930
17 036 0 . 1 2 1.56 (100 (123 4530
18 (122 (181 0.94 034 (120 56.25
19 1.44 0.00 (100 0 . 0 0 (148 2320
2 0 0 . 0 1 0 . 1 1 138 0 34 0 . 1 0 4433
lenge 2
57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX III
SUMMARY OF STATISTICS
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Body Weight Interaction
2 X 2  Mixed N odel ANOVA -  Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet 463.327 I 463327 L7892 . 2 0 1 0
Error (diet) 3884.437 15 258.962
Time 68157.226 1 68157.226 3623750 < . 0 0 0 1
Diet X Time 205.344 I 205344 1.0924 .3125
Error (time) 2819.715 15 187.981
Growth Interaction
2 X 9  Mixed Model ANOVA -  Sphericity not Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet 7344.774 1 7344.774 5.7892 3295
Error (diet) 19030.455 15 1268.697
Time 142243.332 1 142243.322 283.6136 <3001
Diet X Time 1450.861 1 1450.861 2.8928 3096
Error (time) 7523.086 15 501339
Independent Samples t-test
Date t df Sig. (p value)
2/25/05 .8553 13.0275 3339
3/3/05 4.3907 15 .0003
3/11/05 23765 15 .0156
3/17/05 1.4864 15 .0790
3/25/05 3.4880 15 .0017
3/30/05 23862 15 .0153
4/7/05 2.6830 15 .0085
4/15/05 1.5054 15 .0765
4/22/05 1.2532 15 .1147
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Ovarian Fat Pad Analysis
Independent sample t-test
Source t df Sig. (p value)
Ovarian Fat Pads 2.8799 9.4109 .0087
Soleus Muscle Analysis
Independent sample t-test
Source t df Sig. (p value)
Soleus Muscle -.1913 12.3541 .4257
Extensor Digitorum Longus Analysis 
Independent sample t-test
Source t df Sig. (p value)
EDL Weight 3297 15 3099
Area Under the Glucose Concentration Curve Interaction
2 X 2  Mixed Model ANOVA -  Sphericity Assumed
Source Type III Sum of Squares D f
Mean
Square F
Sig.
(p value)
Diet 12456.080 1 12456380 .0071 .9339
Error (diet) 26254517.861 15 1750301.191
Time 899530.015 1 899530.015 1.7634 .2041
Diet X Time 2554206.485 1 2554206.485 5.0071 .0408
Error (time) 7651694.750 15 510112.983
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Dependent Samples t-test
Source t df Sig. (p value)
Control Diet .8210 7 .2194
Protein Diet 3L2222 8 3285
Independent Samples t-test
Source t df Sig. (p value)
AUC 3/17/05 1.2095 15 3226
AUC 4/15/05 -3855 15 3700
Blood Glucose Concentrations Interaction for OGTT 1
2 X 5  Mixed Model ANOVA - Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet 1065.836 1 1065.836 7.0560 3180
Error (diet) 2265.811 15 151.054
Time 23814.757 4 5953.689 38.8589 <.0001
Diet X Time 3064.404 4 766.101 5.0002 .0015
Error (time) 9192.772 60 153.213
Independent Samples t-test
Source t df Sig. (p value)
Baseline 3184 8.4159 3460
15 minutes 1.4423 93463 3902
30 minutes 33486 15 3022
60 minutes -1.7948 15 3465
1 2 0  minutes 1.9713 15 .0337
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Blood Glucose Concentrations Interaction for OGTT 2
2 X 5  Mixed Model ANOVA -  Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet .086 1 .086 3002 3881
Error (diet) 5672.619 15 378375
Time 19491.112 4 4872.778 37.8272 <.0001
Diet X Time 4150.642 4 1037.660 8.0553 <.0001
Error (time) 7729.006 60 128.817
Independent Samples t-test
Source t df Sig. (p value)
Baseline 3325 15 .4097
15 minutes 33863 15 3331
30 minutes 13986 15 .1247
60 minutes -1.7532 12.3658 .0522
1 2 0  minutes -3.8465 15 3008
Area Under the Insulin Concentration Curve Interaction
2 X 2  Mixed Model ANOVA -  Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig- (p
value)
Diet 27L320 I 27E320 3488 .7051
Error (diet) 27347.454 15 1823.164
Time 20517.676 1 20517.676 18.0580 3007
Diet X Time 27.479 1 2T479 3242 3785
Error (time) 17043.191 15 1136.213
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Independent Samples t-test
Source t df Sig. (p value)
AUC 3/17/05 .5425 15 3978
AUC 4/15/05 .1709 15 .4333
Plasma Insulin Concentrations Interaction for OGTT I
2 X 5  Mixed Model ANOVA -  Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet .610 1 .610 1.4754 .2433
Error (diet) 6306 15 .414
Time 4.155 4 1339 3.2227 .0184
Diet X Time 3358 4 389 2.4496 .0557
Error (time) 19338 60 322
Independent Samples t-test
Source t df Sig. (p value)
Baseline 1.1190 15 .1404
15 minutes 1.3146 15 .1042
30 minutes 1.9521 83868 .0414
60 minutes -.1017 15 .4602
1 2 0  minutes -2.0027 8.6516 .0388
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Plasma Insulin Concentrations Interaction for OGTT 2
2 X 5  Mixed Model ANOVA -  Sphericity Assumed
Source
Type III 
Sum of 
Squares
df MeanSquare F
Sig.
(p value)
Diet .097 1 .097 3300 3234
Error (diet) I I . 177 15 .745
Time 1989 4 397 2.0726 3956
Diet X Time 1263 4 316 1.6953 3629
Error (time) 21867 60 .481
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